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SUMMARY 
Setting: A cohort of 5,311 patients reported to the North Carolina Tuberculosis Control 
program from 1993-2003. 
Objective: To examine the leading causes of death in North Carolina tuberculosis 
patients and to determine risk factors for death, in particular deaths due to tuberculosis, in 
this population. 
Design: This is a retrospective cohort study using data extracted from the North Carolina 
Tuberculosis Control Program from 1993-2003 linked to data about time and causes of 
death as recorded on death certificates through the United States National Death Index. 
Results: A total of 1,616 patients died over the study period, representing 30.1% of our 
cohort, with 540 (10.5%) of these deaths occurring during tuberculosis treatment. Risk 
factors for death were increasing age, male sex (OR 1.14 95% CI 1.02-.139), US 
citizenship (OR 4.7 95% CI 2.6-8.5), known HN seropositivity (7.3 95% CI 5.8-9.4) or 
unknown HN status (1.53 95% CI 1.30-1.81) and unknown alcohol status (OR 1.84 95% 
CI 1.52-2.24). Ten percent of deaths in our cohort were due directly to tuberculosis, 
another 13% were due to HN and 22% were due to other pulmonary diseases. Excessive 
alcohol use was associated with an increased risk of death by TB (OR 1. 70, 95% CI 1.01-
2.85) while male sex had a protective effect (OR 0.69 95% CI 0.49-0.98). 
Conclusion: The case-fatality rate in this cohort of North Carolina TB patients remains 
high, with many of these deaths being due either directly to tuberculosis or related 
diseases such as HN or pulmonary disease. 
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TEXT 
INTRODUCTION 
Despite being a curable disease, tuberculosis (TB) represents a substantial burden 
of illness worldwide, being directly responsible for 1.8 million deaths annually [I]. 
While, the TB incidence in the United States has continually decreased every year since 
1993 [2], the case-fatality rate (CPR) of active tuberculosis in the US and other developed 
nations continues to remains unacceptably high; with some studies showing death rates 
up to 20%-28% [3-5]. Much of this high mortality rate is likely due to the age 
distribution of the disease, with adults 65 years of age or older making up 20% of the 
cases in the US and having the highest incidence of disease (7.7 per 100,000, compared 
to 4.6 per 100,000 in the population at large) [2, 6]. Nevertheless, evidence exists that 
there is increased all-cause mortality, as compared to the population at large, even in 
younger patients who complete treatment, with up to a 6-8 fold increase [7-9]. 
There are at least two possible explanations for this increased mortality; 1) 
patients with TB generally have poorer overall health, and their active infection is a 
consequence of this vulnerable health state or 2) the increased mortality is related 
sequelae of active tuberculosis infection and represents long term damage accrued during 
infection. The latter could result in an increased propensity for other pulmonary diseases, 
such as bronchiectasis, COPD, or lung cancer. While some research has shown minimal 
changes in pulmonary function over a short-term period following treatment [10], few 
studies have evaluated the long term consequences of TB infection. 
Previous research on TB mortality has identified risk factors for in patients 
receiving treatment and has found that age, HIV status, other medical co-morbidities, 
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alcohol use, previous TB treatment, and unemployment tend to be associated with an 
increased risk of death during or shortly after treatment (3-5, 9, 11, 12]. Work by 
Gadkowski, Nguyen, Stout and Hamilton further explored risk factors for dying 
depending on when a person died relative to the start of treatment, and found that there 
were significant differences in age, underlying risk factors, and race (13]. In addition to 
age and HIV status, which were strong risk factors for death prior to, during and 
following treatment, they demonstrated that being a US-born black (OR 1.35 95%CI 
1.05-1.75), reporting alcohol use (OR 1.68 95% CI 1.05-1.75) and residing in a long-term 
care facility (OR 1.79 95% CI 1.63-1.97) were all risk factors for dying in the first 8 
weeks of treatment. 
A few retrospective studies have looked into the causes of mortality within the 
population and have found that there is an increase in deaths due to HIV and malignancy, 
particularly lung cancer, in patients diagnosed with TB (4, 7, 9]. Studies have also 
demonstrated that 25-75% of deaths during treatment period are due to causes other than 
tuberculosis [ 14-18] providing evidence of the poor health status of these patients. 
However, the longest follow-up in any of these studies is out to 2 years from the start of 
treatment and therefore limit interpretation of the long-term consequences ofTB 
infection. To our knowledge, no long-term study of causes of mortality in tuberculosis 
patients has previously been done. 
We hypothesize that the most common causes of death among patients with TB 
will vary depending on relative time of death, being more related to the TB illness if 
death occurs soon after the diagnosis ofTB, and being more related to either sequelae of 
TB, or concomitant illnesses if death occurs later. To examine this question, we designed 
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a retrospective cohort study of all patients diagnosed with TB in North Carolina over a 
period often years using a combination of data routinely collected on all cases ofTB and 
data collected for death certificates. Additionally, we will identify risk factors for all-
cause mortality in our cohort as well as what patient characteristics put a person at 
increased risk of dying of TB as opposed to other illness. 
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STUDY POPULATION 
The North Carolina Tuberculosis Control Program (NC TB Program) routinely 
collects data from all reported cases of TB in the state. Data derived from patients 
diagnosed with active TB, either through positive cultures, clinical diagnosis, or during 
autopsy, are recorded on a standardized Report of Verified Case ofTB (RVCT) and 
submitted to the State TB Control Program. This information is then transmitted to the 
Center for Disease Control and Prevention (CDC) using the TB Information Management 
System (TIMS). The RVCT registry contains information on each patient's 
demographics, localization of disease, previous treatment, confirmation of diagnosis and 
epidemiologic and medical risk factors for TB at time of diagnosis. Specifics of the 
initial TB treatment protocol are also included. Individuals who are diagnosed with TB at 
autopsy, or who died during TB treatment are also identified in the RVCT. In our study, 
we included all patients reported to the NC TB program from 1993-2003, representing a 
total of 5,311 total cases. 
The project received approval by the Institutional Review Boards of Duke 
University Health System, the University of North Carolina-Chapel Hill's School of 
Public Health, and the North Carolina Department of Health and Human Services' 
Division of Public Health. 
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METHODS 
The RVCT data were analyzed to identifY individuals who died prior to, or during 
TB therapy. In addition, we used the United States National Death Index (NDI) to 
determine if individuals who were alive at the end ofTB treatment had died prior to 
December 31, 2004; we also used the NDI to confirm the deaths of patients who we 
identified in our RVCT database, and to record the reported cause of death. The NDI is a 
national mortality database that contains death certificate data from all fifty states, Puerto 
Rico, and the Virgin Islands and contains information about the time, location and 
recorded cause of death. We were able to link subjects from the NDI to the RVCT 
database using subjects' Social Security number, full name, date of birth, race, gender 
and last known residence, as entered in the North Carolina TB Control Program's 
database using specific link criteria (appendix B). NDI records that did not fulfill any of 
the criteria were discarded as inaccurate or false matches. Any discrepancies in dates or 
status of patients between the two databases were resolved in favor of the NC TB 
Program's RVCT database. 
The primary outcome of interest in this study is underlying causes of death. The 
NDI provided ICD9 or ICD1 0 underlying cause of death based on the information 
recorded on the death certificate and using standardized CDC death tables. These results 
were subsequently recoded into the following categories based on the ICD code: TB 
(ICD9 010-1018, ICD10 A16-19), HIV/AIDS (ICD9 042-044, ICD10 B20-B24); lung 
cancer (ICD9 160-165, ICD1 0 C32-C39) non-TB/non-neoplastic pulmonary disease 
(ICD9 460-519, ICD10 JOO-J98) and all others. Also of interest in this study was whether 
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TB or HIV was recorded anywhere on the death certificate (other than as the underlying 
cause of death). The multiple causes of death data provided by NDI was reviewed for 
any ICD9/l 0 codes corresponding to HIV or TB using the ranges described above. 
We grouped timing of death into three categories: those who died prior to 
diagnosis, those who died during treatment and those who died after treatment. Patients 
for whom a start date for treatment was not recorded were excluded from these analyses. 
Information on the primary localization of disease as provided by the RVCT was used to 
categorize patients as having pulmonary or extrapulmonary disease. Patients were 
categorized as having pulmonary disease ifthe major site of infection, as recorded on 
RVCT, was indicated as pulmonary or pleural. If anything else was indicated as a major 
site, they were classified as extrapulmonary. 
Bivariate analyses were performed to examine differences in patient 
characteristics amongst the various causes of death. Differences in proportions were 
evaluated using chi-square test or Fisher's exact test as appropriate. T-tests were used to 
evaluate continuous variables. Both all-cause and specific rates for each cause of death 
category were calculated by dividing the number of deaths by a specific cause by the total 
amount of years that the population was at risk. Logistic regression models were used to 
calculate adjusted odds ratios (OR) for risk factors of all-cause mortality and TB-specific 
mortality. All statistics were performed with STAT A version 9.2 (College Station, 
Texas). 
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RESULTS 
All Cause Mortality 
Between January 1993 and December 2003,5,311 cases ofTB were reported to 
the North Carolina TB control program. Demographic characteristics of these patients 
are shown in Table 1. The NDI reported 1,457 matches from January 1993 through 
December 31,2004. The NC TB program reported an additional159 patients who were 
reported as "dead" by county TB programs but were not captured by the NDI query. 
Because we did not have any death certificate data, these patients were included in all-
cause mortality analysis, but not in the analysis on specific causes of death. The total 
number of deceased individuals for our follow-up period was 1 ,616, representing 30.4% 
of the total cohort. Of these, 181 died prior to diagnosis ofTB. Because these patients 
died before contributing any person-time to our cohort, they were removed, resulting in a 
crude mortality rate of 0.050 per person-year. A total of 540 subjects died during 
treatment, with 305 dying in the first 8 weeks. An additional 895 deaths were recorded 
for patients dying after the conclusion of treatment up until our censor date. 
Analysis of risk factors for all cause mortality is shown in table 2. Risk factors 
for death in the unadjusted analysis were increasing age, black race, positive or unknown 
HIV status, unknown alcohol status, previous TB and pulmonary involvement. 
Protective factors were Hispanic ethnicity, Asian/Pacific Islander and foreign birth. 
Multivariate analysis results from a logistic regression model are shown in the second 
column of table 2. In addition to increasing age, other risk factors for death in our cohort 
were male sex (OR 1.19 95% CI 1.02-.139), US citizenship (OR 4. 7, 95% CI 2.6-8.5), 
known HIV seropositivity (7.3 95% CI 5.8-9.4) or unknown HIV status (1.53 95% CI 
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1.30-1.81) and unknown alcohol status (OR 1.84 95% CI 1.52-2.24), all significant at 
p<0.05. Additionally, excessive alcohol use had an adjusted odds ratio of 1.20 (95% CI 
0.99- 1.46). Of note, in the multivariate analysis, race, ethnicity, previous TB diagnosis 
and site of disease were not associated with all-cause mortality. The apparent beneficial 
effects of both ethnicity and foreign-birth seen in the unadjusted analysis reflects the very 
different epidemiology of those groups- most of the foreign-born individuals being 
young Hispanic immigrants - and once age was controlled for in the multivariate 
analysis, the benefit disappeared. 
Cause Specific Deaths 
Out of the 1,457 deaths observed in our cohort, 1,305 were due to causes other 
than TB. A total of 188 deaths were attributed to HIV, 116 to lung cancer and 202 to 
other pulmonary diseases (Figure I). The remaining 799 deaths were due to causes not 
obviously relevant to the diagnosis of TB. Figure 2 shows the number of deaths by each 
cause of interest, stratified by age group. Table 3 shows the demographic breakdown of 
each of the causes of death of interest while Table 4 displays the causes of death by 
relative time period and is described below. In general, deaths in those below the age of 
25 were minimal, however, a substantial portion of those between 25 and 44 died, with 
HIV being the most common cause. In the older age groups, deaths were more likely due 
to tuberculosis or other pulmonary diseases. 
The demographics of this population based on relative time of death have been 
described elsewhere [13]. Ofthe 181 deaths prior to diagnosis, 37 were not found in the 
NDI query but were recorded in the TB database and not included in this analysis. Of the 
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134 deaths that we did have cause of death information about, 20 (14.9%) had 
tuberculosis recorded as an underlying cause of death, 16 (11.9%) had HN recorded, 10 
(7.5%) had lung cancer, and 31 (23.1 %) died of other pulmonary disease. The remaining 
42.5% died of other causes. The overall mean age of patients who died before diagnosis 
was 66.6 (range 24-1 04), however this varied substantially based on cause of death. 
Those who died ofHN were substantially younger (mean age 38) compared to a those 
who died of any other cause (mean age of69.3, p<O.OOl). Patients who died ofTB were 
also substantially older (mean age of71.6). 
A total of540 deaths occurred during treatment, resulting in a case-fatality rate of 
10.5% and representing 33.4% of all deaths observed. Of these, 121 (28.3%) were due 
to tuberculosis, 46 (10.8%) were due to HN, 23 (5.4%) to lung cancer, 54 (12.6%) to 
non-TB/non-neoplastic pulmonary disease; the remaining 184 deaths were due to other 
causes. The 121 TB deaths represent almost all (91. 7%) of the total deaths due to TB. 
The mean age of those who died during treatment was 68.4. 
The remaining 895 (55.4%) of deaths occurred after treatment. The overall raw 
mortality rate for those who died after treatment was 0.0316 per person-year (or 31.6 per 
1000 person-years). Only 11 (1.23%) of these deaths were attributed to tuberculosis, 126 
(14.1 %) were due to HN, 83 (9.3%) were to lung cancer, and 117 (13.1 %) to other 
pulmonary disease. Incidence rates per 100,000 person-years were 38.9, 445.1, 293.2, 
and 413.4 respectively. The median follow-up for all subjects who survived treatment 
was 6.0 years (range 0.47-13.7 years) while the median follow-up for subjects who 
survived treatment, but died prior to our censor date was 3.5 years (range 0.37-12.1 
years). 
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TB Specific deaths 
A total of 152 patients in our cohort had tuberculosis recorded as their underlying 
cause of death, representing 3.0% of our total cohort and 10.4% of the total deaths. An 
additional 165 patients had tuberculosis reported elsewhere on the "multiple cause of 
death" lines of the death certificate, but was not deemed to be the underlying cause of 
death. Results from the logistic regression model of risk factors for TB as an underlying 
cause of death are shown in Table 5. Age was by far the greatest risk factor for death by 
TB, with those over the age of 65 having an adjusted-odds ratio of 30.7 compared to 
those under 25. Excessive alcohol use was associated with an increased risk of death by 
TB (OR 1.70, 95% CI 1.01-2.85) while male sex had a protective effect (OR 0.69 95% CI 
0.49-0.98). Blacks had a trend towards having an increased risk of death (OR 1.4, 
p=0.07), but otherwise race was not predictive of death by TB. Similarly, HN status, 
ethnicity, country of origin, and site of disease were not associated with death by TB. 
Bivariate analysis comparing those who died ofTB to those who died of other 
causes is shown in Table 5. Results of the multivariate analysis are shown in Table 6. In 
the adjusted model, only black race was predictive of a higher likelihood of death by TB 
compared to other causes (OR 1.57 95% CI 1.07-2.30). Again, males were less likely 
than females to die ofTB compared to other causes (OR 0.64 95% CI 0.44-0.91). 
Increasing age was not associated with either an increased or decreased risk of death by 
TB. The odds ratio for positive HN status was 0.15 (95% CI 00.5-0.42); however this 
apparent low risk was because over 80% ofHN positive patients who died had HN 
recorded as their cause of death. Interestingly, only 22 (8.8%) of deceased HN positive 
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patients with a known diagnosis ofTB had TB recorded anywhere on their death 
certificates, which was significantly less than those who were not HIV positive. 
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DISCUSSION 
This paper explored the causes of death in patients reported to the North Carolina 
Tuberculosis control program from 1993 through 2003. Over the follow-up period, 
almost a third (30.4%) of our cohort died. While one would expect a fairly high mortality 
rate in the over 65 population in a study with up to 12 years follow-up, the close to 60% 
fatality rate is still striking. The 25% mortality rate in the 45-64 age group and 14% in 
the 25-44 age groups, groups which are not expected to have significant competing 
causes of death in a normal population, indicate that despite the availability of treatment 
the immediate and long-term effects of tuberculosis are still substantial. During 
treatment, the case fatality rate in our study was I 0.5%, very similar to the rate observed 
in other recent studies in Russia and the United Kingdom (9.6%-11 %) [14, 15]. 
Tuberculosis was recorded as the underlying cause of death in 28.3% of these cases 
which was very close to that seen in these previous papers. The great majority of TB 
deaths occurred prior to or during treatment, with only 11 total occurring after treatment. 
The gender distributions in this study were also interesting. While the higher 
likelihood of all-cause mortality in males might be expected, the increased mortality in 
females due to TB is unexpected. Men have a higher mortality rate in this population due 
to many competing potential causes of death; however, the increased propensity for TB 
death in women is not easily explained. Worldwide, the rate of TB disease in men is 
higher than that in women, though some have speculated that this may be explained by 
differences in reporting. Perhaps while women in general are less likely to develop active 
TB, those who do are demonstrating a subtle, unidentified underlying immune defect, or 
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have other nutritional, medical or social characteristics not captured in standard TB 
surveillance data. [19]. 
One of the major goals of this study was to characterize the causes of death in 
patients with tuberculosis to determine whether TB patients had a higher propensity for 
other disease, puhnonary disease in particular. Previous studies had shown a somewhat 
increased risk of death due to lung cancer [7, 9], though no long term study exploring this 
has been done. In our study, we found that almost a quarter of deaths observed were 
attributed to non-tuberculosis pulmonary disease and one third of those were due to lung 
cancer. 
The lack of information regarding the smoking status of our cohort makes 
interpretation of any increased incidence of pulmonary disease difficult. Tobacco use is a 
well-known risk factor for most pulmonary diseases and therefore represents a significant 
covariate that we were unable to adjust for. Smoking could account for a significant 
portion of the puhnonary disease present; however, the exact smoking rate of our cohort 
is unknown. A recent meta-analysis demonstrated that smoking clearly increases the risk 
ofTB infection (RR 1.7) as well as the development ofTB disease (RR 2.3-2.7) [20]. 
The relationship between smoking, TB and mortality needs to be further explored. 
Unfortunately, because smoking status is not routinely collected on reported TB cases we 
were unable to take this into consideration. Future versions of the RVCT may want to 
include such information to help out future analyses. 
HIVand TB 
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Since the earliest stages of the epidemic, HIV has been known to be a potent risk 
factor for reactivation ofTB. HIV -infected individuals have a 10% per year risk of 
developing active tuberculosis, compared to the 10% lifetime risk of those not infected 
with HIV. A number of reports have also demonstrated that the progression ofTB and 
subsequent mortality can be very rapid [ 1, 21]. In developing countries, tuberculosis 
incident rates are strongly associated with a country's HIV burden, with approximately 
30% ofTB cases in Africa being in HIV-infected individuals [1]. In the nations hardest 
hit by the HIV epidemic, up to 50% of the morbidity and mortality associated with TB is 
in HIV positive individuals. Even if treated successfully for TB, HIV positive patients 
have a 3.7-fold increased risk of developing recurrent TB[22]. In our study, HIV positive 
patients were at a much higher risk of dying than those who were HIV negative (OR 7.3) 
and the majority (81 %) dying of their HIV. Because HIV tends to be a disease ofthe 
younger age groups, it was the primary reason for the increased overall mortality rate in 
the 25 to 44 group in our cohort. 
People who died in our cohort tended to belong to one of two demographic 
groups- either the elderly or the HIV positive. Figures 3 through 5 show the distribution 
of age at diagnosis for all people who subsequently died, those who died who were HIV 
positive, and those who died who were HIV negative, respectively. The overall age 
distribution has a clear bimodal distribution which is almost completely described by 
HIV status. This represents two separate "epidemics" which need to be addressed in 
different ways. 
Limitations 
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This study has several limitations. First, the use of death certificate data, while 
widely used, ~is not a perfect source of cause-of-death data. Some studies have found that 
up to 60% of death certificates are filled in incorrectly [23] and studies relating death 
certificates to autopsy rates have shown relatively poor correlations [24]. A study from 
New York City in the 1990's looking specifically at tuberculosis using death certificates, 
medical records and the state TB registry found that while almost all patients who died of 
TB had been included in the state registry, death certificates often did not mention TB in 
patients known to have the disease [25]. Nevertheless, death certificate data remains the 
primary source for reporting national and state mortality statistic and allows for efficient 
comparisons of populations level data. 
A second limitation of this study is the unknown HN status of much of our 
population, particularly in the earlier cohort diagnosed with TB prior to 1999 when as 
much as 40% of our TB patients had unknown HIV status. With HN being a strong 
predictor of tuberculosis mortality and upwards near 40% of our population of unknown 
status, this lack of information could have a significant impact on our findings. Those 
with unknown HN status in our population tended to be older, possibly reflecting a lower 
perceived risk by either the patient or treating physician and therefore more likely to 
refuse or not be offered testing. While this is a legitimate concern, it is reassuring that 
only one subject of"unknown" HN status during TB treatment had HN listed as a cause 
of death on the death certificate. Based on this finding, I feel comfortable in asserting 
that undiagnosed HN infection likely did not have a major effect on our results. 
Additionally, this study spanned from 1993-2004 during which time highly active 
anti-retroviral (HAART) therapies were developed and subsequently greatly decreased 
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the mortality due to HIV. Because of this, I would expect very different outcomes in 
those HIV positive persons who developed TB earlier in our cohort compared to those 
who developed it later. 
Implications 
This paper demonstrates that the mortality associated with TB is still substantial, 
even in a developed country with a strong public health system. While much of the death 
that occurred in this study was in elderly persons who may have been in poor health to 
begin with, the high case-fatality rate argues that more needs to be done to decrease TB 
mortality, even in the United States. 
More research also needs to be done evaluating the long-term consequences ofTB 
infection. This study has added to the literature demonstrating a potential increase in 
deaths due to pulmonary disease in patients who were successfully treated for TB. While 
it is unclear whether the increased risk of pulmonary-related deaths was due to the 
infection in the past or if previous pulmonary disease put them at risk for developing 
active TB, the interplay between more chronic pulmonary disease and TB is of great 
importance. With 8.3 million new TB cases occurring yearly [1), the global implications 
of the associated long-term damage are vast and would greatly expand the burden of 
disease due to TB. 
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CONCLUSIONS 
This study examined mortality in a cohort of tuberculosis patients reported to the North 
Carolina Tuberculosis Control Program from 1993 through 2003. We demonstrated that 
two different sub-groups of tuberculosis patients were at very high risk for death- the 
elderly and the HIV positive. Those older than 65 years of age were much more likely to 
have tuberculosis recorded as the primary cause of death, and most of these deaths 
occurred soon after beginning treatment. Additionally, while men had an increased risk 
of mortality in this cohort, women appear to be at an increased risk of death due to 
tuberculosis. Even in a developed country with a very strong public health system, 
tuberculosis continues to have a very high case-fatality rate, with almost half of these 
deaths resulting from TB, HIV or puhnonary diseases. 
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TABLES 
Table 1. Characteristics of patients reported to state TB program 
(1993-2003) 
N=5 311 
' 
Age at diagnosis 
<25 551 (10.4%) 
25-44 1614 (30.4%) 
45-64 1522 (28.7%) 
>65 1624 (30.6%) 
Sex 
Male 3477 (65.5%) 
Female 1834 (34.5%) 
Race 
Black 3084 (58.1%) 
White 1872 (35.3%) 
Asian/Pacific Islander 308 (5.8%) 
American Indian/Alaskan Native 44 (0.8%) 
Ethnicity 
Hispanic 559 (10.5%) 
Other 4752 (89.5%) 
Citizenship 
US Citizen 4348 (81.9%) 
Foreign born 959 (18.1%) 
HIV 
Negative 2650 (49.9%) 
Positive 549 (10.3%) 
Unknown 2112 (39.8 %) 
Excess Alcohol Use 
No 3411 (64.2%) 
Yes 1147 (21.6%) 
Unknown 753 (14.2%) 
Previous TB 296 (5.6%) 
Pulmonary TB 4511 (84.9%) 
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Table 2 Multivariate analysis for all cause mortality 
Unadjusted OR Adjusted* OR (95% CI) 
(95% CI) 
Age at diagnosis 
<25 1 I 
25-44 7.6 (4.2- 13.7) 3.6 (2.0-6.7) 
45-64 16.7 (9.2- 30.0) 9.7 (5.4-17.7) 
>65 64.6 (36.2-115.5) 41.0 (22.7-74.0) 
Female 1 1 
Male 1.11 (.98- 1.3) 1.19 (1.02-1.39) 
Race 
White 1 1 
Black 1.14 (1.00- 1.29) 0.91 (0.78 -1.06) 
Asian 0.15 (0.95- 0.25) 0.99 (0.47- 2.12) 
American Indian 1. 76 (0.96- 3.23) 1.41 (0.71- 2.79) 
Etbnicity 
Otber 1 1 
Hispanic 0.01 (0.07- 0.14) 0.76 (0.41-1.40) 
Citizenship 
Foreign born 1 1 
US Citizen 12.7 (9.2 -17.5) 4. 7 (2.6 -8.5) 
HIV 
Negative 1 1 
Positive 3.9 (3.2-4.7) 7.3 (5.8- 9.4) 
Unknown 3.5 (3.1-4.0) 1.53 (1.30 -1.81) 
Alcohol Use 
No 1 1 
Yes 0.95 {0.82-1.1 0) 1.20 (0.99 - 1.46) 
Unknown 2.16 (1.84-2.54) 1.84 (1.52- 2.24) 
Previous TB 
No 1 1 
Yes 1.45 (1.13-1.84) 1.27 (0.96- 1.69) 
Site of infection 
Pulmonary TB 1 1 
Extrapuhnonary 1.36 (1.15-1.62) 1.10 (0.89- 1.35) 
*Adjusted for all nine variables in tbe table. 
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Table 3. Patient characteristics of different underlying causes of death. 
TB (n=l52) HN (n=188) Lung Other All Other 
Cancer Puhnonary (n=799) 
(n=116) (n=202) 
Age at diagnosis 
Mean age 71.5 41.2 66.9 74.5 69.2 
<25 I (0.2%) 2 (0.4%) 0 0 6 (1.1 %) 
25-44 12 (0.8%) 132 (8.3%) 3 (0.2%) 2 (0.1%) 60 (3.8%) 
45-64 25 (1.7%) 51 (3.4%) 43 (2.9%) 35 (2.4%) 225 (15.1%) 
>65 114 (7.5%) 3 (0.2%) 70 (4.6%) 165 (10.8%) 608 (33.3%) 
Sex 
Female 69 (3.9%) 39 (2.2%) 15 (0.8%) 59 (3.3%) 291 (16.4%) 
Male 83 (2.5%) 149 (4.4%) 101 (3.0%) 143(4.2%) 508 (15.1%) 
Race 
Black 102 (3.4%) 166 (5.6%) 64 (2.2%) 78 (2.6%) 500 (16.8%) 
White 47 (2.6%) 21 (1.2%) 52 (2.9%) 119 (6.5%) 277 (15.2%) 
Asian 2 (0.7%) 0 0 I (0.3%) 13(4.3%) 
American Indian I (2.5%) I (2.5%) 0 4 (2.0%) 9 (22.5%) 
Ethnicity 
Other !50 (3.3%) 185 (4.0%) 116 (2.5%) 202 (4.4%) 791 (17.2%) 
Hispanic 2 (0.4%) 3 (0.6%) 0 0 8 (1.5%) 
Citizenship 
US Citizen 149 (3.5%) 183 (4.4%) 116 (2.8%) 201 (4.8%) 783 (18.6%) 
Foreign-born 3 (0.3%) 5 (0.5%) 0 I (0.1 %) 15 (1.6%) 
HN 
Negative 48 (1.8%) I (0.04%) 41 (1.6%) 59 (2.3%) 276 (10.6%) 
Positive 5 (1.0%) 185 (35.0%) 0 2 (0.4%) 37 (7.0%) 
Unknown 99 (4.9%) 2 (0.1%) 75 (3.7%) 141 (7.0%) 486 (24.1 %) 
Alcohol 
No 102 (3.1%) 73 (2.2%) 64 (1.9%) 145 (4.4%) 486 (14.6%) 
Yes 27 (2.4%) 76 (6.8%) 25 (2.2%) 20 (1.8%) 140 (12.5%) 
Unknown 23 (3.3%) 39 (5.5%) 27 (3.8%) 37 (5.2%) 173 (24.5%) 
Previous TB 
No 139 (2.9%) 178 (3.7%) 106 (2.2%) 188 (3.9%) 740 (15.2%) 
Yes 13 (4.6%) 9 (3.2%) 10 (3.5%) 13 (4.6%) 58(20.3%) 
Site of infection 
Extrapulmonary 19 (2.4%) 32 (4.1%) 8 (1.0%) 12 (1.5%) 110 (14.1 %) 
Puhnonary TB 133 (3.0%) !56 (3.6%) 108 (2.5%) 190 (4.4%) 689 (15.8%) 
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Table 4. Causes of death by relative time of death 
All TB HIV Lung Other All Other 
cause Cancer Pulmonary 
Before 134 20 (14.9%) 16 (11.9%) 10 (7.5%) 31 (23.1 %) 57 (42.5%) 
Treatment 
During 428 121 (28.3%) 46 (10.8%) 23 (5.4%) 54 (12.6%) 184 (43.0%) 
Treatment 
After treatment 895 11 (1.2%) 126 (14.1 %) 83 (9.3%) 117 (13.1 %) 558 (62.4%) 
Table 5 Multivariate analysis ofTB deaths 
Unadjusted OR Adjusted* OR 
Age at diagnosis 
<25 1 1 
25-44 4.12 (0.53-31.8) 3.96 (0.50-31.61) 
45-64 9.38 (1.24- 67.9) 6.96 (0.91- 52.94) 
>65 41.76 (5.78- 298.0) 30.7 ( 4.20 - 224.9) 
Sex 
Female 1 1 
Male 0.63 (0.45-0.87) 0.69 (0.49- 0.98) 
Race 
White 1 1 
Black 1.32 (0.94- 1.89) 1.40 (0.97- 2.02) 
Asian 0.25 (0.06-1.05) 2.62 (0.23 - 30.00) 
American Indian 0.90 (0.13 - 6. 70) 0.74 (0.10- 5.60) 
Ethnicity 
Other 1 1 
Hispanic 0.11 (0.03 - 0.45) 1.63 (0.29- 9.25) 
Citizenship 
Foreign born 1 1 
US Citizen 11.31 (3.60- 35.54) 6.38 (0.76- 53.76) 
HIV 
Negative 1 1 
Positive 0.50 (0.20- 1.26) 0.75 (0.29- 1.99) 
Unknown 2.67 (1.88- 3.78) 1.27 (0.85- 1.90) 
Alcohol Use 
No 1 1 
Yes 0. 78 (0.51-1.20) 1.70 (1.01- 2.85) 
Unknown 1.02 (0.65-1.62) 0.92 (0.57- 1.47) 
Previous TB 
No 1 1 
Yes 1.61 (0.90-2.88) 1.46 (0.80- 2.65) 
Site of infection 
Extrapulmonary 1 1 
Pulmonary 1.25 (0.77-2.03) 1.07 (0.644- 1. 77) 
*AdJusted for all nme vanables m the table. 
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Table 6 Bivariate analysis ofTB deaths versus all other deaths§ 
TB death (n=l52) Other death 
(n=l305) 
Age at diagnosis 
<25 1 (11.1%) 8 (88.9%) 
25-44 12 (5.7%) 197 (94.3%) 
45-64 25 (6.6%) 354 (93.4%) 
>65 114 (13.3%)* 746 (86.7%) 
Sex 
Male 83 (8.4%) 901 (91.6%) 
Female 69 (14.6%)* 404 (85.4%) 
Race 
Black 102 (11.2%) 808 (88.8%) 
White 47 (9.1%) 463 (90.9%) 
Asian 2 (12.5%) 14 (87.5%) 
American Indian 1 (6.7%) 14 (93.3%) 
Ethnicity 
Hispanic 2 (15.4%) 11 (84.6%) 
Other 150 (10.4%) 1294 (89.6%) 
Citizenship 149 (10.4%) 1283 (89.6%) 
US Citizen 3 (12.5%) 21 (87.5%) 
Foreign born 
HN 
Negative 48 (11.3%) 377 (88.7%) 
Positive 5 (2.2%)* 224 (97.8%) 
Unknown 99 (12.3%) 704 (87.7%) 
Alcohol Use 
No 102 (11.7%) 768 (88.3%) 
Yes 27 (9.4%) 261 (90.6%) 
Unknown 23 (7.7%) 276 (92.3%) 
Previous TB 
Yes 13 (12.6%) 90 (87.4%) 
No 139 (10.3%) 1212 (89.7%) 
Site of Infection 133 (10.4%) 1143 (89.6%) 
Pulmonary TB 19 (10.5%) 162 (89.5%) 
Extrapuhnonary 
§ S1gmficance tests for compansons based on Pearson's ch1-square test 
* p-value<0.05. 
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Table 7. Multivariate analysis ofTB death compared to death from other causes. 
Unadjusted OR Adjusted* OR 
Age at diagnosis 
<25 1 1 
25-44 0.49 (0.06-4.22) 0.88 (0.09- 8.70) 
45-64 0.56 (0.07-4.70) 0.46 (0.05 - 4.23) 
>65 1.22 (0.15-9.87) 0.93 (0.11 - 8.30) 
Sex 
Female 1 1 
Male 0.54 (0.38-0.76) 0.64 (0.44- 0.91) 
Race 
White 1 1 
Black 1.26 (0.88-1.81) 1.57 (1.07- 2.30) 
Asian 1.43 (0.31-6.46) 0. 72 (0.42- 12.2) 
American Indian 0.71 (0.09-5.54) 0.88 (0.11 - 7 .03) 
Ethnicity 
Other 1 1 
Hispanic 1.57 (0.34-7.14) 1.76 (0.24- 12.69) 
Citizenship 
Foreign born 1 1 
us 0.81 (0.24-2.76) 0.42 (0.33 - 5.19) 
HN 
Negative 1 1 
Positive 0.18 (0.07-0.45) 0.15 (0.05- 0.42) 
Unknown 1.10 (0.77-1.59) 1.04 (0.68- 1.58) 
Alcohol Use 
No 1 1 
Yes 0.78 (0.50-1.22) 1.48 (0.85 - 2.57) 
Unknown 0.63 (0.39-1.00) 0.74 (0.46 -1.21) 
Previous TB 
No 1 1 
Yes 1.26 (0.69-2.31) 1.29 (0.69- 2.40) 
Site of infection 
Extrapulmonary 1 1 
Pulmonary TB 0.99 (0.60-1.65) 0.97 (0.57- 1.65) 
*Adjusted for all other variables listed in this table 
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FIGURES 
Figure 1. Specific causes of death in TB cohort. 
N=l457. 
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Figure 2a. Number dead from each cause by age group. 
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Figure 3. Age distribution at time of diagnosis for all deaths 
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Figure 5. Age distribution ofHIV negative patients who died. 
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APPENDIX A. 
Historical Perspective on TB mortality 
Tuberculosis is an ancient disease that has been a major source of mortality and 
morbidity to humans since it first appeared in the historical record around 1 000 BCE 
[26]. The leading theory on the origins of Mycobacterium tuberculosis states that it 
initially evolved from Mycobacterium bovis, a disease in cows that infected milk-
drinking Indo-European nomads. As is the case with many emerging infectious diseases, 
war and volatile social environments provide an ideal situation for a disease to take root, 
and conflicts between these tribes and other societies provided such an environment. By 
the end ofthe first millennium BCE, TB had spread throughout the world. While theories 
of the infectious nature ofTB had existed for centuries, it was not until1882 that Koch 
discovered the tuberculosis bacilli that definitive evidence was available. By then, TB 
had been well-established as a devastating cause of death and disability worldwide. 
While the actually historical case-fatality rates due to TB is difficult to estimate, 
studies from the 1960's showed that untreated smear-positive tuberculosis has a 25% 
mortality rate after 1.5 years and approximately 50% mortality after 5 years[27]. 
Additionally, these studies demonstrate that close to a third of patients with active TB 
will spontaneously clear their infections without intervention. Some evidence from the 
sanatorium movement, which became the preferred method of treatment from the mid-
1800's to the mid-1900's, showed that it may have been somewhat effective in 
decreasing mortality due to disease, but lack of controlled studies make it difficult to say 
for certain. Many of the post-sanatorium "cure" rates reported were around the 50% rate 
that appears to be the natural history of the disease [28]. During the first half of the 201h 
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century, tuberculosis killed as many people in the U.S. as pneumonia and influenza 
combined, with a mortality rate of approximately 200 per 100,000 [29], 
Following the discovery of the first effective anti-tuberculosis drug, 
streptomycin, in the 1940's, case-fatality rates for those receiving treatment dropped 
substantially as did the overall incidence ofTB in the developed world[29]. Over the 
next several decades, multiple other drugs and treatment protocols were developed which 
were effective in lowering the case-fatality rate even lower. Personalized treatment 
regimens based on susceptibility testing can now decrease mortality to an an estimated 5-
15% for HIV negative patients [27, 30]. Worldwide, the current case fatality rate for TB 
varies greatly depending on region, from 14% in Europe to 34% in Africa; HN 
prevalence also plays a role in CFR, particularly in Africa where 32% of patients with TB 
are also HN positive.[30]. 
In the early 1990's, the World Health Organization began advocating the use of 
DOTS (Directly Observed Therapy- Short Course), a comprehensive strategy that 
focuses on case detection of smear positive patients and directly observed treatment using 
standardized multi-drug treatment. The United Nations has addressed tuberculosis in the 
organization's Millenium Development Goals (MDG 6, target 8) pledging to have "halted 
by 2015 and begun to reverse the incidence ofTB. The Stop TB Partnership of the WHO 
has further defined these goals and set out to halve the prevalence and death rate of TB by 
2015 and ensure that 70% of those infected with TB are in DOTS programs, with an 
ultimate goal of eliminating TB as a public health problem worldwide by 2050. 
Epidemiology ofTB in the United States 
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In 2006, there were 13,767 reported cases ofTB in the United States (4.6 per 
100,000), representing a 3.2% decrease from 2005 and the lowest rate since the recording 
ofTB data began in 1953 [2]. However, the rate of decline has decreased over the past 
seven years, from an average of 7.3% per year in the 1990's, and is currently behind the 
CDC's goals for elimination ofTB as a public health problem by 2010. While TB is no 
longer a generalized epidemic in the US, it instead exists in pockets ofthe population that 
are at a substantially increased risk. 
Foreign-born persons have made up a majority ofTB cases for the sixth 
consecutive year, having an incident rate 9.5 times higher than that of US persons. While 
increased immigration rates explain in part why the number of cases in foreign-born 
persons has been remained effectively unchanged since the early 1990's, minimal 
progress has been made in closing the gap. Racial and ethnic minorities are also at a 
significantly increased risk of developing TB relative to whites, particular blacks (OR 
8.4), Asians (OR 21.2) and Hispanics (OR 7.6),. The CDC recognizes that this is a major 
impediment to TB control, stating that "the slowing of the decline in the overall national 
TB rate and the inability to effectively address persistent disparities in TB rates between 
U.S.-born and foreign-born persons and between whites and racial/ethnic minority 
populations threaten progress toward the goal of eliminating TB in the United States[2]." 
The demographics of TB within the foreign-born population are substantially 
different from that of the US-born. Foreign-born persons with TB tend to be younger, 
with 58.5% ofthe cases occurring in persons< 44 years of age compared to 41.1% within 
this age group in the US-born population. They are also much less likely to have any 
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other established risk factors normally associated with TB, including HN, alcohol or 
drug use, or homelessness[31]. 
In the United States, the risk of developing TB increases with age with 20% of 
cases occurring in those over the age of 65 and 50% occurring in those over the age of 
45[6]. TB is also predominately a disease of men, whose infectionntes are 
approximately double that of females. The 2006 data for the United States showed that 
12.4% ofTB cases were in persons who were also infected with HN, representing a 
4.4% decline from 2005. However, just under one third (31.8%) of reported TB cases 
have an unknown HN status, therefore the decline may be due to under-reporting or lack 
of testing. 
Causes of death in TB patients. Systematic Review. 
In order to determine if other studies had examined the long term causes of death 
in patients diagnosed with TB, I performed a systematic review to identify primary 
research articles that examined this very issue. Using the MESH search terms 
"Tuberculosis" and "Mortality" or "Cause of death" generated 4,293 matches. Despite 
my efforts, I was unable to narrow this search while maintaining the sensitivity necessary 
to find articles of interest. Reading titles I was able to identify 446 articles that appeared 
to focus on mortality during or following TB treatment and potentially would describe 
causes of death and obtained their abstracts. I also read references of relevant papers in 
order to identify other potential articles. From these abstracts I identified only seven 
articles that specifically addressed causes of death in patients with tuberculosis. I have 
described these relevant articles in more detail below. 
35 
Mathew et a! [ 15] performed a retrospective analysis of Russian data looking at 
causes of death during tuberculosis treatment. Similar to our study, the authors used 
death certificate data to determine the underlying cause of death, referring to medical 
records when the death certificate data was unclear. Overall they found a 9.6% mortality 
rate during treatment with 25% of these deaths not being attributed to TB. Those who 
died directly due to TB were significantly more likely to die early in treatment, with 21% 
dying in the first week. Standardized mortality ratios were calculated for deaths other 
than TB in 4 categories (cancer, vascular disease, external causes, and other) using 
national death rates for the year 2000, stratified by 5-year age and sex categories. While 
the power for this analysis was low (only 23 deaths were not due to TB) an increased 
incidence of vascular disease (SMR 1.75, 95% CI 1.45-2.09) and "all other causes"-
anything but vascular disease, cancer, or external causes - (SMR 11. 79, 95% CI 10.85-
12.79) was found. 
A retrospective study of 439 TB cases Liverpool from 1989-1996 found a total of 
104 deaths leading to a standardized mortality rate (SMR) 11-fold higher than the general 
population despite adequate treatment [7]. Review of these patient's death certificates 
found that significant differences based on the age of the patients. While a majority of 
the patients over the age of 7 5 died of TB or bronchopneumonia; for those under the age 
of 75 lung cancer was a significant cause of death in this population with a crude death 
rate up to 30 times higher than that of the general Liverpool population. The authors did 
not report the smoking rates of their cohort, but do imply that a majority were smokers. 
A recent population based study [14], which followed 575 English TB patients 
through treatment up to one year following diagnosis found an all-cause mortality rate of 
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11% with 57% of the deaths were "TB-related", though no further information about the 
actual cause of death was collected. Another case-control study of 1083 reported TB 
cases looked at risk factors for dying from tuberculosis during the treatment period [16]. 
Of the 127 who died prior to treatment completion, TB was determined to be the primary 
cause of death in 53 and a contributing factor in another 34 deaths. Risk factors for death 
by TB included increasing age as well as co-existing malnutrition, renal disease, and liver 
disease. Of the unrelated deaths 16 were attributed to cardio-pulmonary diseases, 20 to 
disease of other organs, 8 due to malignancy and I to AIDS. 
Sterling et a! reported the causes of death in patients who took part in a large 
tuberculosis therapy trial [9]. This clinical trial randomized patients to receive one of 
two different medication regimens for the last 4 months of treatment and followed them 
for 24 months. No difference between these groups was observed in this analysis. Of the 
1075 patients enrolled in the study, 71 died over the follow-up period. This mortality rate 
of those enrolled was significantly higher than that of the general population, despite the 
fact that these patients tended to be of free of other comorbidities and received very 
controlled treatments. Malignancy was the most common cause of death, being 
responsible for a total of 14 deaths in the cohort. Alcohol-related deaths were also 
significant. While the detail provided in this study was good, as a clinical trial, it is less 
relevant to typical TB infection and treatment. 
White et a! [ 17]looked at death certificate data over a ten year period from 1980-
1990, concentrating on records that had tuberculosis listed anywhere on the certificate. 
They found that half of death certificates with TB listed anywhere on them had a non-TB 
cause listed as the underlying cause of death and that people dying ofTB typically had 
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greater than 3 causes listed, though a more in depth review of causes was not provided. 
Finally, another older study [ 18] examined the cause of death all patients who died with 
active TB in San Antonio Chest Hospital from 1979-1983 finding half of deaths being 
directly due to TB and half"unrelated", though the findings of this study have less 
external validity as the population- those who were admitted to a specialized hospital for 
TB- would not be very representative ofthe typical TB patient. 
Overall, tuberculosis seems to be directly responsible for somewhere between 
25%-75% of deaths that occur during treatment in these studies. What is most surprising 
about these findings is the high proportion of deaths from unrelated causes that occur in 
these patients. This appears indicative of the generally poor health status of developed 
world TB patients. Their tuberculosis results from re-activation oflatent disease due to 
their failing immune systems in the setting of their increased age and co-morbidities. 
While the evidence is far from compelling, TB patients may appear to be at some 
increased risk for malignancy, however, not many studies evaluated this and co-variates, 
such as smoking, were not addressed. 
This review also demonstrates the major lack of studies providing long-term 
follow up of patients diagnosed with tuberculosis. Only two of these studies provided 
information which extended beyond treatment, and even then the longest only went out a 
maximum of two years. With so many people worldwide being treated for tuberculosis 
and surviving, there is a definite need for more prospective cohort studies to determine 
whether these patients do indeed have increased mortality relative to the population at 
large. 
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APPENDIX BLink criteria applied to the results of the NDI query to distinguish 
correctly linked NDVRVCT records from false or inaccurate links. 
If the patient's SSN is available: 
1) SSN, first name, last name, middle initial, DOB, gender, race and state of residency 
2) first name, last name, middle initial, DOB, gender, race and SSN with either one 
incorrect digit or 2 consecutive incorrect digits 
3) SSN, DOB, gender and race 
4) SSN, first name, last name, day and/or month of birth and year of birth+/- 3 years 
5) SSN, last name, day of birth, month of birth and year of birth +/-1 0 years. 
If the SSN was not available and the subject's last name was not among the two 
hundred fifty most frequent U.S. last names/ then the following criteria were used: 
1) first name, last name, middle initial, DOB, state of residence and gender 
2) first name, last name, middle initial, DOB, gender and race 
3) first name, last name, DOB, gender, and race 
4) first initial, middle initial, last name, DOB and state of residence 
5) first name, New York State Identification and Intelligence System (NYSIIS)-coded 
last name, DOB, state of residence, gender and race 
6) first name, last name, DOB +I- 1 year, state of residence, gender and race. 
1 The NDI provides files listing the top two hundred fifty most frequent last names in the United States in 
both alphabetical order and in order of decreasing frequency. 
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